Researchers identify potential new therapy for drug-resistant cancer by targeting TDP1 and CDK1 enzymes.

Researchers at India’s Indian Association for the Cultivation of Science have identified a potential new therapy for drug-resistant cancer. Their study reveals that cancer cells activate the DNA repair enzyme TDP1 to survive existing treatments. By targeting both TDP1 and the CDK1 enzyme, they propose a combination therapy that may enhance treatment effectiveness and disrupt cancer cell survival. This approach could lead to advancements in precision medicine for resistant cancers.

October 10, 2024
6 Articles